Predictors of response and disease course in patients with inflammatory bowel disease treated with biological therapy—the Danish IBD Biobank Project: protocol for a multicentre prospective cohort study
IntroductionInflammatory bowel diseases (IBDs) are chronic diseases of unknown cause characterised by a progressive and unpredictable disease course. In the last decade, biological treatment has become a cornerstone in the treatment of IBD. However, one-in-three-to-four patients do not respond to fi...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-02-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/10/2/e035756.full |
id |
doaj-c859877fa38a418bac4032695d08e826 |
---|---|
record_format |
Article |
spelling |
doaj-c859877fa38a418bac4032695d08e8262021-07-31T15:32:06ZengBMJ Publishing GroupBMJ Open2044-60552020-02-0110210.1136/bmjopen-2019-035756Predictors of response and disease course in patients with inflammatory bowel disease treated with biological therapy—the Danish IBD Biobank Project: protocol for a multicentre prospective cohort studyJakob Benedict Seidelin0Andreas Munk Petersen1Johan Burisch2Flemming Bendtsen3Mirabella Zhao4Lone Larsen5Christian Hvas6Gastro Unit, Medical Division, Herlev University Hospital, Herlev, DenmarkGastro Unit, Medical Division, Hvidovre University Hospital, Hvidovre, DenmarkGastrounit, Medical Division, Copenhagen University Hospital, Hvidovre, Hvidovre, DenmarkGastro Unit, Medical Division, Hvidovre University Hospital, Hvidovre, DenmarkGastro Unit, Medical Division, Hvidovre University Hospital, Hvidovre, DenmarkDepartment of Gastroenterology and Hepatology, Aalborg University Hospital, Aalborg, DenmarkDepartment of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, DenmarkIntroductionInflammatory bowel diseases (IBDs) are chronic diseases of unknown cause characterised by a progressive and unpredictable disease course. In the last decade, biological treatment has become a cornerstone in the treatment of IBD. However, one-in-three-to-four patients do not respond to first-line biological agents and another third of patients see their response diminish over time. This highlights an unmet need for optimising the use of biologicals and the prediction of treatment response. Considering the multifaceted nature of IBD, we hypothesise that multiomics profiling of sequential samples from single patients could facilitate the discovery of predictive biomarkers of response to biological therapy and disease course.MethodsThis is a multicentre prospective cohort study which will enrol 840 biological-naïve patients with IBD who initiate biological therapy in a 3-year period. Primary outcomes are the occurrence of primary non-response (evaluated at weeks 14–16) and loss of response (evaluated during entire follow-up in patients who obtain partial or full response after induction period). Each patient will be followed up for their clinical data for at least 1 year or till the end of study period (up to 4 years). Blood and stool samples will be collected sequentially during the first year of biological treatment. Intestinal tissue will be sampled after 1 year of treatment and whenever an endoscopy is performed. Samples will undergo transcriptomic, proteomic and microbial DNA analyses. Omics data will be integrated with clinical data to identify a panel of predictive biomarkers of response to biological therapy and disease behaviour in patients with IBD.Ethics and disseminationEthical approval has been obtained from the Danish Ethics Committee (H-18064178). Inclusion is ongoing at three study centres and will be initiated in two additional centres. Both positive and negative study results will be disseminated through peer-reviewed journals according to Strengthening the Reporting of Observational Studies in Epidemiology guidelines, as well as presented at international conferences.https://bmjopen.bmj.com/content/10/2/e035756.full |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jakob Benedict Seidelin Andreas Munk Petersen Johan Burisch Flemming Bendtsen Mirabella Zhao Lone Larsen Christian Hvas |
spellingShingle |
Jakob Benedict Seidelin Andreas Munk Petersen Johan Burisch Flemming Bendtsen Mirabella Zhao Lone Larsen Christian Hvas Predictors of response and disease course in patients with inflammatory bowel disease treated with biological therapy—the Danish IBD Biobank Project: protocol for a multicentre prospective cohort study BMJ Open |
author_facet |
Jakob Benedict Seidelin Andreas Munk Petersen Johan Burisch Flemming Bendtsen Mirabella Zhao Lone Larsen Christian Hvas |
author_sort |
Jakob Benedict Seidelin |
title |
Predictors of response and disease course in patients with inflammatory bowel disease treated with biological therapy—the Danish IBD Biobank Project: protocol for a multicentre prospective cohort study |
title_short |
Predictors of response and disease course in patients with inflammatory bowel disease treated with biological therapy—the Danish IBD Biobank Project: protocol for a multicentre prospective cohort study |
title_full |
Predictors of response and disease course in patients with inflammatory bowel disease treated with biological therapy—the Danish IBD Biobank Project: protocol for a multicentre prospective cohort study |
title_fullStr |
Predictors of response and disease course in patients with inflammatory bowel disease treated with biological therapy—the Danish IBD Biobank Project: protocol for a multicentre prospective cohort study |
title_full_unstemmed |
Predictors of response and disease course in patients with inflammatory bowel disease treated with biological therapy—the Danish IBD Biobank Project: protocol for a multicentre prospective cohort study |
title_sort |
predictors of response and disease course in patients with inflammatory bowel disease treated with biological therapy—the danish ibd biobank project: protocol for a multicentre prospective cohort study |
publisher |
BMJ Publishing Group |
series |
BMJ Open |
issn |
2044-6055 |
publishDate |
2020-02-01 |
description |
IntroductionInflammatory bowel diseases (IBDs) are chronic diseases of unknown cause characterised by a progressive and unpredictable disease course. In the last decade, biological treatment has become a cornerstone in the treatment of IBD. However, one-in-three-to-four patients do not respond to first-line biological agents and another third of patients see their response diminish over time. This highlights an unmet need for optimising the use of biologicals and the prediction of treatment response. Considering the multifaceted nature of IBD, we hypothesise that multiomics profiling of sequential samples from single patients could facilitate the discovery of predictive biomarkers of response to biological therapy and disease course.MethodsThis is a multicentre prospective cohort study which will enrol 840 biological-naïve patients with IBD who initiate biological therapy in a 3-year period. Primary outcomes are the occurrence of primary non-response (evaluated at weeks 14–16) and loss of response (evaluated during entire follow-up in patients who obtain partial or full response after induction period). Each patient will be followed up for their clinical data for at least 1 year or till the end of study period (up to 4 years). Blood and stool samples will be collected sequentially during the first year of biological treatment. Intestinal tissue will be sampled after 1 year of treatment and whenever an endoscopy is performed. Samples will undergo transcriptomic, proteomic and microbial DNA analyses. Omics data will be integrated with clinical data to identify a panel of predictive biomarkers of response to biological therapy and disease behaviour in patients with IBD.Ethics and disseminationEthical approval has been obtained from the Danish Ethics Committee (H-18064178). Inclusion is ongoing at three study centres and will be initiated in two additional centres. Both positive and negative study results will be disseminated through peer-reviewed journals according to Strengthening the Reporting of Observational Studies in Epidemiology guidelines, as well as presented at international conferences. |
url |
https://bmjopen.bmj.com/content/10/2/e035756.full |
work_keys_str_mv |
AT jakobbenedictseidelin predictorsofresponseanddiseasecourseinpatientswithinflammatoryboweldiseasetreatedwithbiologicaltherapythedanishibdbiobankprojectprotocolforamulticentreprospectivecohortstudy AT andreasmunkpetersen predictorsofresponseanddiseasecourseinpatientswithinflammatoryboweldiseasetreatedwithbiologicaltherapythedanishibdbiobankprojectprotocolforamulticentreprospectivecohortstudy AT johanburisch predictorsofresponseanddiseasecourseinpatientswithinflammatoryboweldiseasetreatedwithbiologicaltherapythedanishibdbiobankprojectprotocolforamulticentreprospectivecohortstudy AT flemmingbendtsen predictorsofresponseanddiseasecourseinpatientswithinflammatoryboweldiseasetreatedwithbiologicaltherapythedanishibdbiobankprojectprotocolforamulticentreprospectivecohortstudy AT mirabellazhao predictorsofresponseanddiseasecourseinpatientswithinflammatoryboweldiseasetreatedwithbiologicaltherapythedanishibdbiobankprojectprotocolforamulticentreprospectivecohortstudy AT lonelarsen predictorsofresponseanddiseasecourseinpatientswithinflammatoryboweldiseasetreatedwithbiologicaltherapythedanishibdbiobankprojectprotocolforamulticentreprospectivecohortstudy AT christianhvas predictorsofresponseanddiseasecourseinpatientswithinflammatoryboweldiseasetreatedwithbiologicaltherapythedanishibdbiobankprojectprotocolforamulticentreprospectivecohortstudy |
_version_ |
1721246769247944704 |